IceCure Medical (ICCM)
(Real Time Quote from BATS)
$0.75 USD
+0.05 (7.65%)
Updated Jul 23, 2024 12:20 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
ICCM 0.75 +0.05(7.65%)
Will ICCM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ICCM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ICCM
IceCure's (ICCM) ProSense Breast Cancer Study Meets Endpoint
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod
ICCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
IceCure Medical (ICCM) Moves to Buy: Rationale Behind the Upgrade
Doximity (DOCS) Q4 Earnings and Revenues Surpass Estimates
ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates
Other News for ICCM
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society
IceCure ProSense® Shows Remarkable Cancer Results
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification
IceCure Medical receives non-compliance notice for continued listing from Nasdaq
IceCure Medical receives noncompliance notification from Nasdaq